Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. MJA 2004;181:492--7.R. I. Baker, P. B. Coughlin, A. S. Gallus, P. L. Harper, H. H. Salem, and E. M. Wood, "Warfarin reversal: consensus guidelines, on behalf of the ...
Correction: Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Haemostasis and Thrombosis RI Baker,PB Coughlin,HH Salem,... - 《Medical Journal of Australia》 被引量: 4发表: 2005年 Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of ...
In March 2013 the Australasian Society of Thrombosis and Haemostasis published an update of the Consensus Guidelines for Warfarin Reversal.3 We reviewed the prescribing practices at Capital and Coast District Health Board (CCDHB), following publication of the updated guidelines.Patients were identified ...
The only 4F-PCC indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, eg, warfarin) therapy in adult patients with: Need for urgent surgery/invasive procedure or Acute major bleeding ...
Higher doses must be considered for more rapid and complete reversal of anticoagulation by the SC route. PATIENTS TAKING long-term oral anticoagulant therapy with warfarin sodium require close monitoring to maintain their coagulation values within therapeutic range. However, fluctuations in the intensity...
Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999;159(22):2721–4. ArticlePubMedGoogle Scholar Fiore LD, Scola MA, Cantillon CE, Brophy MT. Anaphylactoid reactions to vitamin K. J Throm...
Reversing the anticoagulant effect of warfarin with phytonadione: What is the right dose? Inappropriate dosing of phytonadione in the reversal of anticoagulation may place patients at high risk of an acute thromboembolic event if warfarin resistance develops. Specific dosage guidelines are relatively uncomm...
Most of the new anticoagulants under development are not being introduced together with potential antidotes. However, the complexity of antithrombotic therapy is increasing. Triple therapy with warfarin, aspirin, and clopidogrel is becoming more frequent, and the risk of bleeding has thus far not been...
16 Similarly, US guidelines recommend an INR target <1.4 in patients with VKA-associated ICH.25 Therefore, patients with INR <2 may still need warfarin reversal. However, there is no recommended strategy to guide the reversal of warfarin in patients with an INR <2; the optimal dose of 4F-...
While warfarin-related intracranial hemorrhage (ICH) occurs in 0.25%-1.1% patients per year, little is known about the practice and outcomes of anticoagula... D Yung,MK Kapral,E Asllani,... - 《Canadian Journal of Cardiology》 被引量: 97发表: 2012年 Abstract NS7: Time To Reversal Is Bra...